A Phase II Randomized Study of Topical Intrarectal Administration of Amifostine for the Prevention of Acute Radiation-Induced Rectal Toxicity

Purpose:   To investigate the cytoprotective effect of intrarectal amifostine administration on acute radiation-induced rectal toxicity.